Related references
Note: Only part of the references are listed.Proton pump inhibitors and fracture risk. The HUNT study, Norway
M. Hoff et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Real-world effectiveness of osteoporosis treatment in the oldest old
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Hennie G. Raterman et al.
DRUGS (2019)
Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway
M. Hoff et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Akeem A. Yusuf et al.
ARCHIVES OF OSTEOPOROSIS (2018)
Effects of alendronate for treatment of glucocorticoid-induced osteoporosis A meta-analysis of randomized controlled trials
Ya-Kang Wang et al.
MEDICINE (2018)
The emperor redressed: treating osteoporosis to prevent hip fractures in the oldest old
B. Abrahamsen
JOURNAL OF INTERNAL MEDICINE (2017)
Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study
Peter Nordstrom et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2017)
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway
M. Hoff et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Real-Life and RCT Participants: Alendronate Users Versus FITs' Trial Eligibility Criterion
Carlen Reyes et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate
Esther M. M. van de Glind et al.
DRUGS & AGING (2016)
Postmenopausal Osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
Bo Abrahamsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
Bo Abrahamsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Bisphosphonates for steroid-induced osteoporosis
Claire S. Allen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy
Kristy Lglay et al.
CLINICAL THERAPEUTICS (2015)
Subclinical Thyroid Dysfunction and Fracture Risk A Meta-analysis
Manuel R. Blum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Use of anti-osteoporotic drugs in central Norway after a forearm fracture
Mari Hoff et al.
ARCHIVES OF OSTEOPOROSIS (2015)
Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures An Updated Systematic Review
Carolyn J. Crandall et al.
ANNALS OF INTERNAL MEDICINE (2014)
Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
Irene E. M. Bultink et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Cohort Profile: The HUNT Study, Norway
S. Krokstad et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs-an analysis using national health databases
K. R. Olsen et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
Helene M. Devold et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Inflammatory Rheumatic Disorders and Bone
Irene E. M. Bultink et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes
Dawn C. Mackey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway
Helene M. Devold et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
FRAX (R) and its applications to clinical practice
John A. Kanis et al.
BONE (2009)
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
G. A. Wells et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Share Paper
